Latest code release is live with fixes to most major bugs resulting from our 15-month rewrite of the underlying code base, including: Ignores, Ignore Replies, View Thread, Hide Replies, Inbox Folder Access, & other random issues. Please report any remaining bugs you are aware of & we'll get cranking on the next round of fixes. Send PM to Admin, email to admin@investorvillage.com. Thanks!
Re: With a share price of5 and change. Why wouldn't we be buying hand over mist?
ZIOP just had a major bull run from 4.xx all the way to 6.xx. The strength in that stock over a several week period was incredible. I'm not sure if it was people front running expected PIII data or a partnership or what, but given how much it's already pulled back, I wouldn't be a seller of ZIOP at current levels. Right now, I've got a ZIOP position that is about the same size as my SGMO position. I'm not nearly as much a fan of ZIOP as I am SGMO long term, but I think the next 6 months with PIII data is going to be VERY good to ZIOP. Much more so than anything I expect out of SGMO over that same time frame. With good PIII data, which I expect, I think ZIOP will be the first of the two stocks to hit double digits. Over the next 365 days, if SGMO can show good HIV results, I wouldn't be surprised if both stocks were 100-200% higher. All IMO.
